Applied Immunesciences Report issue

For profit Phase 1
Founded: Santa Clara CA United States (1993)
Status: Acquired by Rhone-Poulenc Rorer (1995) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
1999
NCT00000680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (2)

aldesleukin (Proleukin) (1 trial)

zidovudine (retrovir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2